Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results

Authors: Poddubnyy, Denis, Sieper, Joachim, Akar, Servet, Muñoz-Fernández, Santiago, Haibel, Hildrun, Hojnik, Maja, Ganz, Fabiana, Inman, Robert D

Source: Rheumatology. 61(8):3299-3308

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165967189.0x000001&indx=1&recIds=ETOCvdc_100165967189.0x000001

Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis

Authors: Maksymowych, Walter P, Baraliakos, Xenofon, Lambert, Robert G, Landewé, Robert, Sandoval, David, Carlier, Hilde, Lisse, Jeffrey, Li, Xiaoqi, Hojnik, Maja, Østergaard, Mikkel ^*

Source: In The Lancet Rheumatology September 2022 4(9):e626-e634

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study

Authors: Coates, Laura C., Pillai, Sreekumar G., Tahir, Hasan, Valter, Ivo, Chandran, Vinod, Kameda, Hideto, Okada, Masato, Kerr, Lisa, Alves, Denise, Park, So Young, Adams, David H., Gallo, Gaia, Hufford, Matthew M., Hojnik, Maja, Mease, Philip J., Kavanaugh, Arthur, Ahmed, Khalid, Barkham, Nicholas, Belhorn, Linda, Bichovska, Daniela, Blahova, Michaela, Bortlik, Ladislav, Breedt, Johannes, Brooks, Michael, Caldron, Paul, Ciernik, Silvia, Daniluk, Stefan, Diegel, Roger, Dobrovodsky, Pavol, Dokoupilova, Eva, Teran Estrada, Leobardo, Garcia, Francisco Javier Blanco, Garmish, Olena, Gasanov, Iurii, Geneva‐Popova, Mariela, Goddard, David, Golovchenko, Oleksandr, Gruszecka, Katarzyna, Hala, Tomas, Hejlova, Jolana, Howell, Mary, Ilivanova, Elena, Jajoo, Ramina, Kaliszuk‐Kaminska, Ewa, Kapandjieva, Nadezhda, Klein, Steven, Korkosz, Mariusz, Krpciar, Milan, Alonso Martinez, Dolores, Matsiliza, Nomawethu, Mazurek, Marcin, Miakisz, Małgorzata, Mueller, Eric, Müller, Raili, Myasoutova, Leysan, Nadashkevych, Oleh, Fernandez Nebro, Antonio, Nemec, Petr, Neuwelt, Clark, Oza, Meera, Pail, Margus, Colunga Pedraza, Iris, Penev, Dimitar, Podrazilova, Lucie, Potts, Jennifer‐Anne, Pulka, Grazyna, Raussi, Eve‐Kai, Reddy, Riteesha, Rekalov, Dmytro, Rell‐Bakalarska, Maria, Rodriguez, Juan Cruz Rizo, Roussou, Euthalia, Rychlewska‐Hanczewska, Anna, Navarro Sarabia, Federico, Sedova, Liliana, Shahouri, Shadi, Shevchuk, Sergii, Sikes, David, Simova, Lubomira, Skublova, Andrea, Socik‐Pojawa, Małgorzata, Solomon, Sheldon, Spargo, Catherine, Stanislavchuk, Mykola, Stehlikova, Helena, Stejfova, Zuzana, Stopinska‐Polaszewska, Maria, Swierkocka, Katarzyna, Tälli, Sandra, Tarr, Gareth, Tena, Cesar Francisco Pacheco, Timanikova, Erika, Tseluyko, Vira, Urbanova, Zuzana, Hernandez Vargas, Edgar, Vasylets, Viktoriia, Galvan Villegas, Federico, Vitek, Petr, Wronisz, Monika, Zelenkova, Hana

Source: Arthritis & rheumatology. 73(9):1663-1672

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132331506.0x000001&indx=1&recIds=ETOCvdc_100132331506.0x000001

Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases

Authors: Elewaut, Dirk, Braun, Jürgen, Anderson, Jaclyn K., Arikan, Dilek, Chen, Su, Hojnik, Maja, De Craemer, Ann-Sophie, Curtis, Jeffrey R.

Source: Arthritis care & research. 73(2):289-295

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114332362.0x000001&indx=1&recIds=ETOCvdc_100114332362.0x000001

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Authors: Morin, Frederic, Rahman, Proton, Ariel, Federico, Berman, Alberto, Carrio, Judith, Lucero, Eleonora, Cocco, Jose Maldonado, Hidalgo, Rodolfo Pardo, Velasco, Jorge, Viola, Diego O., Grisar, Johannes, Resch, Heinrich, Scheinecker, Clemens, Melazzi, Ana Claudia, Roimicher, Luis, Scotton, Antonio Scafuto, Rodriguez, Aaron Alejandro Barrera, Molina, Francisco Fidencio Cons, Barragan, Sergio Duran, Skinner, Cassandra M., Tena, Cesar Francisco Pacheco, Remus, Cesar Ricardo Ramos, Rodriguez, Juan Cruz Rizo, Hong, Seung-Jae, Kang, Seong Wook, Lee, Chang Keun, Lee, Eun Bong, Lee, Sang Heon, Park, Min-Chan, Lee, Sang-Hoon, Dokoupilova, Eva, Dvorak, Zdenek, Malcova, Martina, Pvelka, Karel, Eklund, Kari K., Jarvinen, Pentti, Karjalainen, Anna, Paimela, Leena, Taniguchi, Yoshinori, Tsuda, Tokutaro, Tada, Kurisu, Dobashi, Hiroaki, Inui, Kentaro, Ueki, Yukitaka, Matsumoto, Yoshifuji, Hatta, Kazuhiro, Atsumi, Tatsuya, Goto, Hitoshi, Honjo, Shigeru, Matsui, Kiyoshi, Takakubo, Yuya, Neeck, Gunther, Wagner, Sylke, Braun, Jürgen, Blicharshi, Tomasz, Dudek, Anna, Hrycai, Pawel, Plebanski, Rafal, Drabiszcak-Piatkowska, Janina, Brzezicki, Jan, Krogulec, Marek, Opris-Belinski, Daniela, Ramazan, Ana Maria, Tronaru, Luminita, van de Sande, Marleen G., Matsievskaya, Galina, Schmidt, Evgeniya, Stanislav, Marina, Yakushin, Sergey, Ershova, Olga, Rebroy, Andrey, Churchill, Melvin A., Flint, Kathleen P., Greenwald, Maria, Howell, Mary P., Kaine, Jeffrey L., Kivitz, Alan, Klein, Steven J., Mueller, Eric C., Peters, Eric A., Querubin, Roel, Sayers, Michael E., Scoville, Craig D., Shanahan, Joseph C., Roseff, Richard, Hull, John E., Mallepalli, Jyothi R., Sebai, Mohamed B., Kimmel, Steven C., Goddard, David H., Mease, Philip J., Harris, Mark D., Mabaquiao, Arthur R., Diegel, Roger J., Thai, Christine, Rivera, Tania L., Perez-De Jesus, Amarilis, Soto-Raices, Oscar, Toro-Torres, Ramon, Pantojas, Carlos, Deodhar, Atul, van der Heijde, Désirée ^*, Gensler, Lianne S, Kim, Tae-Hwan, Maksymowych, Walter P, Østergaard, Mikkel, Poddubnyy, Denis, Marzo-Ortega, Helena, Bessette, Louis, Tomita, Tetsuya, Leung, Ann, Hojnik, Maja, Gallo, Gaia, Li, Xiaoqi, Adams, David, Carlier, Hilde, Sieper, Joachim

Source: In The Lancet 4-10 January 2020 395(10217):53-64

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Authors: Deodhar, Atul, van der Heijde, Désirée, Gensler, Lianne S, Kim, Tae-Hwan, Maksymowych, Walter P, Østergaard, Mikkel, Poddubnyy, Denis, Marzo-Ortega, Helena, Bessette, Louis, Tomita, Tetsuya, Leung, Ann, Hojnik, Maja, Gallo, Gaia, Li, Xiaoqi, Adams, David, Carlier, Hilde, Sieper, Joachim

Source: Lancet. 395(10217):53-64

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097122980.0x000001&indx=1&recIds=ETOCvdc_100097122980.0x000001

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial

Authors: van der Heijde, Désirée, Sieper, Joachim, Maksymowych, Walter, Lambert, Robert, Chen, Su, Hojnik, Maja, Anderson, Jaclyn, Pangan, Aileen

Source: Arthritis research & therapy. 20(1):1-13

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161533179.0x000001&indx=1&recIds=ETOCvdc_100161533179.0x000001

Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice

Authors: Khobzey, Kuzma, Liskova, Iryna, Szegedi, Andrea, Pavlovsky, Lev, Lunder, Tomaž, Kingo, Külli, Miljković, Jovan, Péč, Juraj, Bohinc, Maša, Hojnik, Maja

Source: Acta dermatovenerologica Alpina, Pannonica et Adriatica. 26(1):11-14

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN610478722&indx=1&recIds=ETOCRN610478722

Anti- β2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease

Authors: Salobir, Barbara, Šabovič, Mišo, Hojnik, Maja, Čučnik, Saša, Kveder, Tanja

Source: In Immunobiology 2007 212(3):193-199

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).

Authors: Landewé, Robert B. M., Gensler, Lianne S., Poddubnyy, Denis, Rahman, Proton, Hojnik, Maja, Xiaoqi Li, Soyi Liu Leage, Adams, David, Carlier, Hilde, Van den Bosch, Filip, Landewé, Robert Bm, Li, Xiaoqi, Liu Leage, Soyi, COAST-Y study group

Source: Annals of the Rheumatic Diseases; Aug2021, Vol. 80 Issue 8, p1022-1030, 9p

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.

Authors: Smolen, Josef S., Mease, Philip, Tahir, Hasan, Schulze-Koops, Hendrik, de la Torre, Inmaculada, Lingnan Li, Maja Hojnik, Sapin, Christophe, Masato Okada, Caporali, Roberto, Gratacós, Jordi, Goupille, Philippe, Leage, Soyi Liu, Pillai, Sreekumar, Nash, Peter, Li, Lingnan, Hojnik, Maja, Okada, Masato, Liu Leage, Soyi

Source: Annals of the Rheumatic Diseases; Oct2020, Vol. 79 Issue 10, p1310-1319, 10p

Subject Terms: THERAPEUTIC use of monoclonal antibodies, PSORIATIC arthritis, RESEARCH, RESEARCH methodology, EVALUATION research, MEDICAL cooperation, ANTIRHEUMATIC agents, TREATMENT effectiveness, COMPARATIVE studies, RANDOMIZED controlled trials, QUESTIONNAIRES

This result is not displayed to guests.
Login for full access.

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.

Authors: Landewé, Robert, Ritchlin, Christopher T, Aletaha, Daniel, Zhang, Ying, Ganz, Fabiana, Hojnik, Maja, Coates, Laura C

Source: Rheumatology; Jun2019, Vol. 58 Issue 6, p1025-1033, 9p, 2 Charts, 2 Graphs

Subject Terms: METHOTREXATE, SYMPTOMS, ADALIMUMAB, C-reactive protein, COMBINATION drug therapy, PSORIATIC arthritis, STATISTICS, DATA analysis, RANDOMIZED controlled trials, TREATMENT effectiveness, DISEASE remission, BLIND experiment, DISEASE progression, PREVENTION, THERAPEUTICS

This result is not displayed to guests.
Login for full access.

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large crosssectional study.

Authors: Smolen, Josef S., Gladman, Dafna, McNeil, H. Patrick, Mease, Philip J., Sieper, Joachim, Hojnik, Maja, Nurwakagari, Pascal, Weinman, John

Source: RMD Open; 1/11/2019, Vol. 5, p1-13, 13p

This result is not displayed to guests.
Login for full access.

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial.

Authors: Mease, Philip J., Kavanaugh, Arthur, Coates, Laura C., McInnes, Iain B., Hojnik, Maja, Ying Zhang, Anderson, Jaclyn K., Dorr, Alexander P., Gladman, Dafna D.

Source: RMD Open; 7/18/2017, Vol. 3 Issue 1, p1-9, 9p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Anti‐β2‐glycoprotein I antibodies in children with atopic dermatitis.

Authors: Ambrožič, Aleš, Avičin, Tadej, Ichikawa, Kenji, Kveder, Tanja, Matsuura, Eiji, Hojnik, Maja, Atsumi, Tatsuya, Rozman, Blaž, Koike, Takao

Source: International Immunology; Jul2002, Vol. 14 Issue 7, p823-830, 8p